Stratified Medicine to Optimise the Treatment of Patients with Hepatitis c Virus Infection (STOP-HCV) (Joint with Universities of Oxford, Bristol, Glasgow, Edinburgh, Southampton, Birmingham, Nottingham, London & LHTM)

Project Details

Effective start/end date16/09/1315/09/19


  • Medical Research Council (MR/K01532X/1 STOP HCV): £42,942.00
  • Genome-wide Association Study for Alcohol-related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1

    Innes, H., Buch, S., Hutchinson, S., Guha, I. N., Morling, J. R., Barnes, E., Irving, W., Forrest, E., Pedergnan, V., Goldberg, D., Aspinall, E., Barclay, S., Hayes, P., Dillon, J., Nischalke, H. D., Lutz, P., Spengler, U., Fischer, J., Berg, T., Brosch, M. & 11 others, Eyer, F., Datz, C., Mueller, S., Peccerella, T., Deltenre, P., Marot, A., Soyka, M., McQuillin, A., Morgan, M. Y., Hampe, J. & Stickel, F., Oct 2020, In: Gastroenterology. 159, 4, p. 1276-1298.e7 21 p.

    Research output: Contribution to journalArticlepeer-review